| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 9.463 | 13.733 | 51.986 | 61.024 | 56.632 | 70.856 | 43.426 | 40.496 | 88.033 |
| Total Income - EUR | - | 9.463 | 13.733 | 51.986 | 61.024 | 56.632 | 70.856 | 43.431 | 40.508 | 88.033 |
| Total Expenses - EUR | - | 331 | 717 | 862 | 996 | 1.239 | 1.740 | 1.207 | 1.363 | 2.156 |
| Gross Profit/Loss - EUR | - | 9.133 | 13.016 | 51.124 | 60.028 | 55.393 | 69.116 | 42.223 | 39.144 | 85.877 |
| Net Profit/Loss - EUR | - | 8.849 | 12.604 | 49.564 | 58.197 | 53.773 | 67.033 | 40.947 | 33.007 | 72.412 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Diabetmark Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 78 | 550 | 323 | 588 | 283 | 95 | 2.688 | 1.777 |
| Current Assets | - | 9.251 | 12.873 | 50.447 | 58.470 | 53.575 | 67.216 | 43.835 | 33.232 | 76.788 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 379 | 4.371 | 17.246 | 7.882 | 751 | 6.028 | 34.484 | 4.200 | 7.971 |
| Cash | - | 8.873 | 8.503 | 33.201 | 50.588 | 52.824 | 61.188 | 9.351 | 29.032 | 68.818 |
| Shareholders Funds | - | 8.893 | 12.657 | 49.616 | 58.248 | 53.823 | 67.081 | 40.995 | 33.055 | 72.460 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 358 | 295 | 1.381 | 546 | 340 | 418 | 2.934 | 2.865 | 6.181 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diabetmark Srl